IL17A and colitis: However, after treatment with L.p R3 or/and MSLZ, the anti-inflammatory factor IL-10 levels were increased and the value of IL-10/IL-17A ratio was significantly increased (p < 0.05) in the DSS-induced colitis mice (Fig. 5B).